Literature DB >> 30054232

How Macrolide Antibiotics Work.

Nora Vázquez-Laslop1, Alexander S Mankin2.   

Abstract

Macrolide antibiotics inhibit protein synthesis by targeting the bacterial ribosome. They bind at the nascent peptide exit tunnel and partially occlude it. Thus, macrolides have been viewed as 'tunnel plugs' that stop the synthesis of every protein. More recent evidence, however, demonstrates that macrolides selectively inhibit the translation of a subset of cellular proteins, and that their action crucially depends on the nascent protein sequence and on the antibiotic structure. Therefore, macrolides emerge as modulators of translation rather than as global inhibitors of protein synthesis. The context-specific action of macrolides is the basis for regulating the expression of resistance genes. Understanding the details of the mechanism of macrolide action may inform rational design of new drugs and unveil important principles of translation regulation.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  antibiotic; ketolide; macrolide; resistance; ribosome; translation

Mesh:

Substances:

Year:  2018        PMID: 30054232      PMCID: PMC6108949          DOI: 10.1016/j.tibs.2018.06.011

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  88 in total

1.  Effects of a number of classes of 50S inhibitors on stop codon readthrough during protein synthesis.

Authors:  Jill Thompson; Catherine A Pratt; Albert E Dahlberg
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

2.  Sequence selectivity of macrolide-induced translational attenuation.

Authors:  Amber R Davis; David W Gohara; Mee-Ngan F Yap
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

3.  A Small-Molecule Anti-secretagogue of PCSK9 Targets the 80S Ribosome to Inhibit PCSK9 Protein Translation.

Authors:  Donna N Petersen; Julie Hawkins; Wanida Ruangsiriluk; Kimberly A Stevens; Bruce A Maguire; Thomas N O'Connell; Benjamin N Rocke; Markus Boehm; Roger B Ruggeri; Tim Rolph; David Hepworth; Paula M Loria; Philip A Carpino
Journal:  Cell Chem Biol       Date:  2016-10-13       Impact factor: 8.116

4.  Structural basis for the antibiotic activity of ketolides and azalides.

Authors:  Frank Schlünzen; Jörg M Harms; Francois Franceschi; Harly A S Hansen; Heike Bartels; Raz Zarivach; Ada Yonath
Journal:  Structure       Date:  2003-03       Impact factor: 5.006

5.  The ermC leader peptide: amino acid alterations leading to differential efficiency of induction by macrolide-lincosamide-streptogramin B antibiotics.

Authors:  M Mayford; B Weisblum
Journal:  J Bacteriol       Date:  1990-07       Impact factor: 3.490

6.  A tunnel in the large ribosomal subunit revealed by three-dimensional image reconstruction.

Authors:  A Yonath; K R Leonard; H G Wittmann
Journal:  Science       Date:  1987-05-15       Impact factor: 47.728

7.  Structural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureus.

Authors:  Zohar Eyal; Donna Matzov; Miri Krupkin; Itai Wekselman; Susanne Paukner; Ella Zimmerman; Haim Rozenberg; Anat Bashan; Ada Yonath
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-13       Impact factor: 11.205

8.  The Ribosomal Protein uL22 Modulates the Shape of the Protein Exit Tunnel.

Authors:  Itai Wekselman; Ella Zimmerman; Chen Davidovich; Matthew Belousoff; Donna Matzov; Miri Krupkin; Haim Rozenberg; Anat Bashan; Gilgi Friedlander; Jette Kjeldgaard; Hanne Ingmer; Lasse Lindahl; Janice M Zengel; Ada Yonath
Journal:  Structure       Date:  2017-07-06       Impact factor: 5.006

9.  The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome.

Authors:  Tanel Tenson; Martin Lovmar; Måns Ehrenberg
Journal:  J Mol Biol       Date:  2003-07-25       Impact factor: 5.469

10.  Nascent peptide assists the ribosome in recognizing chemically distinct small molecules.

Authors:  Pulkit Gupta; Bo Liu; Dorota Klepacki; Vrinda Gupta; Klaus Schulten; Alexander S Mankin; Nora Vázquez-Laslop
Journal:  Nat Chem Biol       Date:  2016-01-04       Impact factor: 15.040

View more
  49 in total

Review 1.  Ribosome protection by ABC-F proteins-Molecular mechanism and potential drug design.

Authors:  Rya Ero; Veerendra Kumar; Weixin Su; Yong-Gui Gao
Journal:  Protein Sci       Date:  2019-03-04       Impact factor: 6.725

Review 2.  Comparison of Antibiotic Resistance Mechanisms in Antibiotic-Producing and Pathogenic Bacteria.

Authors:  Hiroshi Ogawara
Journal:  Molecules       Date:  2019-09-21       Impact factor: 4.411

3.  Alternative approaches utilizing click chemistry to develop next-generation analogs of solithromycin.

Authors:  Samer S Daher; Miseon Lee; Xiao Jin; Christiana N Teijaro; Pamela R Barnett; Joel S Freundlich; Rodrigo B Andrade
Journal:  Eur J Med Chem       Date:  2022-02-24       Impact factor: 6.514

4.  Three critical regions of the erythromycin resistance methyltransferase, ErmE, are required for function supporting a model for the interaction of Erm family enzymes with substrate rRNA.

Authors:  Rory E Sharkey; Johnny B Herbert; Danielle A McGaha; Vy Nguyen; Allyn J Schoeffler; Jack A Dunkle
Journal:  RNA       Date:  2021-11-18       Impact factor: 4.942

5.  Identification of Eltrombopag as a Repurposing Drug Against Staphylococcus epidermidis and its Biofilms.

Authors:  Juan Zhu; Pengfei She; Juhua Fu; Canhui Peng; Yong Wu
Journal:  Curr Microbiol       Date:  2021-02-21       Impact factor: 2.188

6.  Clarithromycin Exerts an Antibiofilm Effect against Salmonella enterica Serovar Typhimurium rdar Biofilm Formation and Transforms the Physiology towards an Apparent Oxygen-Depleted Energy and Carbon Metabolism.

Authors:  Munirah Zafar; Humera Jahan; Sulman Shafeeq; Manfred Nimtz; Lothar Jänsch; Ute Römling; M Iqbal Choudhary
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

7.  Effects of azithromycin on treating chronic obstructive pulmonary disease with acute exacerbation of chronic bronchitis in the stable phase.

Authors:  Yangfei Lu; Xiaobo Wang; Jun Zhao
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

8.  Context-specific action of macrolide antibiotics on the eukaryotic ribosome.

Authors:  Maxim S Svetlov; Timm O Koller; Sezen Meydan; Vaishnavi Shankar; Dorota Klepacki; Norbert Polacek; Nicholas R Guydosh; Nora Vázquez-Laslop; Daniel N Wilson; Alexander S Mankin
Journal:  Nat Commun       Date:  2021-05-14       Impact factor: 14.919

9.  Structural basis of ABCF-mediated resistance to pleuromutilin, lincosamide, and streptogramin A antibiotics in Gram-positive pathogens.

Authors:  Caillan Crowe-McAuliffe; Victoriia Murina; Kathryn Jane Turnbull; Marje Kasari; Merianne Mohamad; Christine Polte; Hiraku Takada; Karolis Vaitkevicius; Jörgen Johansson; Zoya Ignatova; Gemma C Atkinson; Alex J O'Neill; Vasili Hauryliuk; Daniel N Wilson
Journal:  Nat Commun       Date:  2021-06-11       Impact factor: 14.919

Review 10.  Macrolides: From Toxins to Therapeutics.

Authors:  Kiersten D Lenz; Katja E Klosterman; Harshini Mukundan; Jessica Z Kubicek-Sutherland
Journal:  Toxins (Basel)       Date:  2021-05-12       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.